| Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha JC DeWitt, A Shnyra, MZ Badr, SE Loveless, D Hoban, SR Frame, ... Critical reviews in toxicology 39 (1), 76-94, 2009 | 297 | 2009 |
| Peroxisome proliferator‐activated receptors and cancer: challenges and opportunities J Youssef, M Badr British journal of pharmacology 164 (1), 68-82, 2011 | 194 | 2011 |
| Role of peroxisome proliferator‐activated receptors in inflammation control J Youssef, M Badr BioMed Research International 2004 (3), 156-166, 2004 | 177 | 2004 |
| Expression of cyclooxygenase‐2 and peroxisome proliferator‐activated receptor‐γ and levels of prostaglandin E2 and 15‐deoxy‐Δ12,14‐prostaglandin J2 in … AF Badawi, MZ Badr International Journal of Cancer 103 (1), 84-90, 2003 | 118 | 2003 |
| Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models AA Qureshi, X Tan, JC Reis, MZ Badr, CJ Papasian, DC Morrison, ... Lipids in health and disease 10, 1-25, 2011 | 108 | 2011 |
| Mechanism of hepatotoxicity to periportal regions of the liver lobule due to allyl alcohol: role of oxygen and lipid peroxidation. MZ Badr, SA Belinsky, FC Kauffman, RG Thurman The Journal of pharmacology and experimental therapeutics 238 (3), 1138-1142, 1986 | 104 | 1986 |
| Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin AA Qureshi, X Tan, JC Reis, MZ Badr, CJ Papasian, DC Morrison, ... Lipids in Health and Disease 10, 1-22, 2011 | 89 | 2011 |
| Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor γ AF Badawi, MB Eldeen, Y Liu, EA Ross, MZ Badr Cancer research 64 (3), 1181-1189, 2004 | 87 | 2004 |
| Activation of peroxisome proliferator-activated receptor γ in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema J Morgenweck, OS Abdel-Aleem, KC McNamara, RR Donahue, MZ Badr, ... Neuropharmacology 58 (2), 337-345, 2010 | 86 | 2010 |
| Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-γ AF Badawi, MZ Badr International Journal of Oncology 20 (6), 1109-1122, 2002 | 84 | 2002 |
| Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia BK Taylor, N Dadia, CB Yang, S Krishnan, M Badr Inflammation 26, 121-127, 2002 | 66 | 2002 |
| Mechanism of hepatotoxicity in periportal regions of the liver lobule due to allyl alcohol: studies on thiols and energy status. SA Belinsky, MZ Badr, FC Kauffman, RG Thurman The Journal of pharmacology and experimental therapeutics 238 (3), 1132-1137, 1986 | 63 | 1986 |
| Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-γ synergistically induces apoptosis and inhibits growth of human breast cancer cells MS Michael, MZ Badr, AF Badawi International journal of molecular medicine 11 (6), 733-736, 2003 | 60 | 2003 |
| Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver ML Cunningham, MS Soliman, MZ Badr, HB Matthews Cancer letters 95 (1-2), 93-97, 1995 | 59 | 1995 |
| Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease J Youssef, M Badr Critical reviews in toxicology 28 (1), 1-33, 1998 | 55 | 1998 |
| Enhanced potential for oxidative stress in hyperinsulinemic rats: imbalance between hepatic peroxisomal hydrogen peroxide production and decomposition due to hyperinsulinemia L Xu, MZ Badr Hormone and metabolic research 31 (04), 278-282, 1999 | 52 | 1999 |
| Biology of senescent liver peroxisomes: role in hepatocellular aging and disease. J Youssef, M Badr Environmental Health Perspectives 107 (10), 791-797, 1999 | 47 | 1999 |
| Mechanism of aluminum-induced inhibition of hepatic glycolysis: inactivation of phosphofructokinase. ZX Xu, L Fox, S Melethil, L Winberg, M Badr The Journal of pharmacology and experimental therapeutics 254 (1), 301-305, 1990 | 43 | 1990 |
| Protection of Liver by Calcium Entry Blockersa RG Thurman, E Apel, M Badr, JL Lemasters Annals of the New York Academy of Sciences 522 (1), 757-770, 1988 | 43 | 1988 |
| Kinetics of aluminum in rats. III: Effect of route of administration ZX Xu, JP Tang, M Badr, S Melethil Journal of pharmaceutical sciences 81 (2), 160-163, 1992 | 40 | 1992 |
